Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 2Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) 1Hepatic Veno-Occlusive Disease 1Disease 1Chemical and Drug Induced Liver Injury 1Adenoma 1

Interventions

Magnetic Resonance Imaging 2Cryosurgery 2imetelstat 1Waiting Lists 1Transcutaneous Electric Nerve Stimulation 1S-Adenosylmethionine 1Prostatectomy 1Pluvicto 1Observation 1Nivolumab 1Mammography 1High-Intensity Interval Training 1Hematologic Tests 1Fluorodeoxyglucose F18 1Exercise 1Equipment and Supplies 1Educational Status 1Diagnostic Techniques and Procedures 1Diagnosis, Computer-Assisted 1Bupivacaine 1Blood Specimen Collection 1Artificial Intelligence 1Arginine 1Acupressure 12-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1(225)Ac-PSMA-617 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × S-Adenosylmethionine × 90 days × Clear all
NCT07582003 2026-05-12

A Phase I Trial of S-Adenosylmethionine (SAMe) for Chemoprevention of Colorectal Adenomas

Cedars-Sinai Medical Center

Phase 1 Not yet recruiting
18 enrolled
Gastrointestinal

Adenoma, Disease, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡